Article Citation
Palee S, Chattipakorn S, Phrommintikul A, Chattipakorn N. PPARγ activator, rosiglitazone: Is it beneficial or harmful to the cardiovascular system? World J Cardiol 2011; 3(5): 144-152 [PMID: 21666815 DOI: 10.4330/wjc.v3.i5.144]
Please LOGIN to submit a new comment.